|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Direct operating expense | |||||
| Selling, general and administrative expense | |||||
| Depreciation and amortization expense | |||||
| Transaction and integration costs | |||||
| Restructuring costs and other | |||||
| Regulatory Matter and Legal Fees | |||||
| Net loss on divestiture of business | |||||
| Operating income | |||||
| Other income (expense), net | |||||
| Interest expense, net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Net income attributable to Noncontrolling Interests (“NCI”) | |||||
| Net income attributable to GXO | |||||
| Earnings per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares outstanding used in computation of earnings per share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
